1. Home
  2. LEGN vs AAL Comparison

LEGN vs AAL Comparison

Compare LEGN & AAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • AAL
  • Stock Information
  • Founded
  • LEGN 2014
  • AAL 1930
  • Country
  • LEGN United States
  • AAL United States
  • Employees
  • LEGN N/A
  • AAL N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • AAL Air Freight/Delivery Services
  • Sector
  • LEGN Health Care
  • AAL Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • AAL Nasdaq
  • Market Cap
  • LEGN 7.0B
  • AAL 6.9B
  • IPO Year
  • LEGN 2020
  • AAL N/A
  • Fundamental
  • Price
  • LEGN $27.91
  • AAL $11.77
  • Analyst Decision
  • LEGN Strong Buy
  • AAL Hold
  • Analyst Count
  • LEGN 13
  • AAL 15
  • Target Price
  • LEGN $75.67
  • AAL $13.87
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • AAL 65.8M
  • Earning Date
  • LEGN 05-13-2025
  • AAL 04-24-2025
  • Dividend Yield
  • LEGN N/A
  • AAL N/A
  • EPS Growth
  • LEGN N/A
  • AAL 35.09
  • EPS
  • LEGN N/A
  • AAL 1.02
  • Revenue
  • LEGN $728,303,000.00
  • AAL $54,192,000,000.00
  • Revenue This Year
  • LEGN $65.96
  • AAL $1.73
  • Revenue Next Year
  • LEGN $52.55
  • AAL $5.94
  • P/E Ratio
  • LEGN N/A
  • AAL $11.53
  • Revenue Growth
  • LEGN 112.46
  • AAL 1.92
  • 52 Week Low
  • LEGN $29.27
  • AAL $8.50
  • 52 Week High
  • LEGN $60.87
  • AAL $19.10
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 28.84
  • AAL 60.91
  • Support Level
  • LEGN $27.43
  • AAL $11.47
  • Resistance Level
  • LEGN $33.30
  • AAL $12.45
  • Average True Range (ATR)
  • LEGN 1.77
  • AAL 0.41
  • MACD
  • LEGN -0.58
  • AAL 0.24
  • Stochastic Oscillator
  • LEGN 2.18
  • AAL 75.08

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About AAL American Airlines Group Inc.

American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest fleet of US legacy carriers.

Share on Social Networks: